Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMD effects on subgingival microbiome in furcation therapy
NCT02907528Completed
- Sponsor
- The Ohio State University
- Start
- Jan 2014
- Primary completion
- Dec 2014
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
Randomised trial of enamel matrix derivative in chronic periodontitis (3 arms), sponsored by The Ohio State University. Primary endpoint: Shifts in the subgingival microbiome at 6 months. Started Jan 2014; status: completed.
02
Drugs
enamel matrix derivative
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on NCT02907528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02907528.